Seres Therapeutics, Inc. Interest Income (Expense), Nonoperating, Net
Seres Therapeutics, Inc. (MCRB) reported Interest Income (Expense), Nonoperating, Net of $335.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2019-11-05
- Seres Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2019-09-30 was $335.00K, a 27.86% increase year-over-year.
- Seres Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2019-06-30 was $189.00K, a 45.85% decline year-over-year.
- Seres Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2019-03-31 was $220.00K, a 36.60% decline year-over-year.
- Seres Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2018-12-31 was $214.00K.
- Seres Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2018 was $1.17M, a 26.29% decline from fiscal 2017.
- Seres Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2017 was $1.59M, a 26.19% increase from fiscal 2016.
- Seres Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2016 was $1.26M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2019-09-30 | $335.00K 10-Q · filed 2019-11-05 | $524.00K derived: sum of 2 quarters · filed 2019-11-05 | $744.00K 10-Q · filed 2019-11-05 | $958.00K derived: sum of 4 quarters · filed 2019-11-05 |
| 2019-06-30 | $189.00K 10-Q · filed 2019-08-06 | $409.00K 10-Q · filed 2019-08-06 | $623.00K derived: sum of 3 quarters · filed 2019-08-06 | $885.00K derived: sum of 4 quarters · filed 2019-11-05 |
| 2019-03-31 | $220.00K 10-Q · filed 2019-05-02 | $434.00K derived: sum of 2 quarters · filed 2019-05-02 | $696.00K derived: sum of 3 quarters · filed 2019-11-05 | $1.04M derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $476.00K derived: sum of 2 quarters · filed 2019-11-05 | $825.00K derived: sum of 3 quarters · filed 2019-11-05 | $1.17M 10-K · filed 2019-03-06 |
| 2018-09-30 | $262.00K 10-Q · filed 2019-11-05 | $611.00K derived: sum of 2 quarters · filed 2019-11-05 | $958.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $349.00K 10-Q · filed 2019-08-06 | $696.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $347.00K 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $1.59M 10-K · filed 2019-03-06 | |||
| 2016-12-31 | $1.26M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |